Señales de obligación según ISO 7010, Protección facial obligatoria, 100 mm, 1 pieza

(8R,9S,13S,14S,17R)-13-METHYL-6,7,8,9,11,12,14,15,16,17-DECAHYDROCYCLOPENTA[A]PHENANTHRENE-3,17-DIOL, 95.0%, 1g

HO-dpeg(8)-co-otbu, 95.0%, 500mg

1-(2-aminoethyl)-1,2-dihydro-3,6-pyridazinedione hydrochloride, 95.0%, 5g

(4-Fluoro-phenyl)-methanesulfonyl chloride, 95.0%, 25g

ethyl 8-(2,4-difluorophenyl)-8-oxooctanoate, 97.0%, 1g

Methyl 3-(2-((5-(3,5-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)acetamido)benzoate, 97%, 25mg

Ethyl 4-benzylmorpholine-2-carboxylate hydrochloride, 95.0%, 1g

(1R,4R)-4-ethyl-4'-(3,4,5-trifluorophenyl)-1,1'-bi(cyclohexane), 97%, 25g

(9H-fluoren-9-yl)methyl N-(2-((4-(4-(3-bromo-4-fluorophenyl)-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1,2,5-oxadiazol-3-yl)amino)ethyl)sulfamoylcarbamate, 98%, 100mg

6,6'-Di-tert-butyl-2,2'-bipyridine, 98%, 1g

4-Fluoro-2-methoxybenzoic acid, 98.0%, 5g

(S)-(-)-4-[2-(DIPHENYLPHOSPHINO)-1-NAPHTHALENYL]-N-[(R)-1-PHENYLETHYL]-1-PHTHALAZINAMINE, 95%, 250mg